U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073677) titled 'A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients' on July 09.
Brief Summary: This study aims to evaluate the efficacy and safety of IN-115314 Ointment in mild to moderate atopic dermatitis adult patients
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Mild to Moderate Atopic Dermatitis
Intervention:
DRUG: IN-115314 Ointment 1%
Twice daily(BID), for 56 day
DRUG: IN-115314 Ointment 3%
Twice daily(BID), for 56 day
DRUG: IN-115314 Ointment placebo
Twice daily(BID), IN-115314 Ointment Placebo for 28 days+ IN-115314 Ointment 3% for 28 days...